MTHFR Gene Testing: What You Actually Need to Know

The MTHFR Buzz on Social Media

If you’ve spent any time on TikTok or Instagram, you’ve probably seen influencers talking about MTHFR gene mutations as the hidden cause of everything from fatigue to anxiety to infertility. Some wellness personalities have built entire brands around methylation testing, often selling expensive supplement protocols alongside their content. As a naturopathic doctor who has been working with genetic testing for over a decade, I want to provide some balanced, evidence-based perspective on this topic.

What Is the MTHFR Gene?

The MTHFR gene provides instructions for producing the methylenetetrahydrofolate reductase enzyme. This enzyme plays a key role in processing folate (vitamin B9) and is involved in the methylation cycle, a biochemical process that affects DNA repair, neurotransmitter production and detoxification.

What Is Methylation?

Methylation is the attachment of a methyl group (one carbon, three hydrogen atoms) to another molecule. Although simple, this process is critical for:

• Turning gene expression on and off as needed¹
• Protecting DNA from damage^2,3,4
• Recycling neurotransmitters including serotonin, melatonin and epinephrine
• Building immune cells, including natural killer cells⁵
• Maintaining the protective myelin coating on nerve cells⁶

MTHFR Variants Are Extremely Common

Here’s something important that often gets lost in the social media conversation: MTHFR variants are not rare mutations, they’re extremely common genetic variations.

Studies show that approximately 40-60% of the population carries at least one copy of the C677T variant, and about 85% of people have some form of MTHFR polymorphism²⁴. This means having an MTHFR variant puts you in the majority, not the minority.

The Problem with MTHFR Testing: What Medical Guidelines Say

In 2013, the American College of Medical Genetics published guidelines advising against routine MTHFR genetic testing²⁵. This recommendation has been supported by numerous other medical organizations including:

• American College of Obstetrics and Gynecology
• American Academy of Family Physicians
• American Heart Association
• College of American Pathologists

Why would these organizations recommend against testing for something that affects methylation? The key insight is this: in the absence of elevated homocysteine levels, MTHFR variants alone are not a risk factor for disease²⁶.

The Better First Step: Homocysteine Testing

If the concern is whether your methylation pathways are functioning properly, there’s a simpler, cheaper and more clinically useful test: measuring homocysteine levels in your blood.

Homocysteine is an amino acid that accumulates when methylation isn’t working well. Here’s the practical approach:

• If homocysteine is normal: Your methylation is working fine, regardless of your MTHFR status. No intervention needed.
• If homocysteine is elevated: Treatment with B vitamins (folate, B12, B6) is the same whether or not you have an MTHFR variant.

This is why many clinicians now test homocysteine first. It tells you directly whether there’s a functional problem, rather than revealing a genetic variant that may or may not be causing any issues.

When MTHFR Testing May Be Appropriate

There are specific situations where genetic testing for MTHFR can provide useful information:

• Severe hyperhomocysteinemia that doesn’t respond to standard B vitamin treatment
• Suspected homocystinuria (a rare metabolic disorder) after other causes have been ruled out
• Family history of known pathogenic MTHFR variants causing homocystinuria
• Personal interest in understanding your genetic makeup (with proper counseling about interpretation)

What Can Interrupt Methylation?

While MTHFR variants get most of the attention, methylation can be affected by several factors:

• Nutrient deficiencies: Folate, zinc, vitamin B2, B6, B12, magnesium or cysteine
• Environmental toxins: Heavy metals, particularly lead⁷
• Certain medications: Including alcohol⁸, nitrous oxide⁹ and proton pump inhibitors (antacids)¹⁰
• Other genetic variants: Including GSTM1, PEMT, MAT, GAMT and CBS

Supporting Healthy Methylation

Regardless of your MTHFR status, these evidence-based strategies support methylation:

Dietary approaches:

• Consume folate-rich foods: leafy greens, legumes, asparagus, broccoli
• Include B12 sources: meat, fish, eggs, dairy (or supplement if plant-based)
• Eat foods containing B6: poultry, fish, potatoes, bananas

Lifestyle factors:

• Limit alcohol consumption
• Discuss alternatives to proton pump inhibitors with your doctor if taking long-term
• Minimize exposure to environmental toxins

Supplementation (when indicated):

• If homocysteine is elevated, methylated forms of folate (5-MTHF) and B12 (methylcobalamin) may be helpful
• Work with a healthcare provider to determine appropriate doses

The Bottom Line

MTHFR gene variants are common and, for most people, don’t require any intervention. The social media narrative around MTHFR often exaggerates its significance and promotes expensive testing and supplement protocols that may not be necessary.

If you’re concerned about methylation, start with a homocysteine blood test. If levels are normal, your methylation is working fine. If levels are elevated, treatment is straightforward and doesn’t require genetic testing to implement.

Methylation and Genetic Testing in Halifax

If you have questions about methylation, homocysteine levels or whether genetic testing might be appropriate for your situation, please contact Dr. Colin MacLeod ND to book an initial visit. Dr. MacLeod offers comprehensive lab testing services and can help you navigate this topic with an evidence-based approach. Dr. MacLeod has completed formal training with Dr. Ben Lynch ND, an expert in the field of methylation.

References

1. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev. 1991 Sep;55(3):451-8.
2. Kisseljova NP, Zueva ES, Pevzner VS, Grachev AN, Kisseljov FL. Methylation of CpG islands in cancer. Mol Biol (Mosk). 1998 Jan;12(1):203-9.
3. Vasu K, Nagaraja V. Diverse functions of restriction-modification systems. Microbiol Mol Biol Rev. 2013 Mar;77(1):53-72.
4. Zilberman D. The evolving functions of DNA methylation. Curr Opin Plant Biol. 2008 Oct;11(5):554-9.
5. Dobenecker MW, Kim JK, Marcello J, Fang TC, Prinjha R, Bosselut R, Tarakhovsky A. Coupling of T cell receptor specificity to natural killer T cell development. J Exp Med. 2015 Mar 9;212(3):297-306.
6. Kim S, Lim IK, Park GH, Paik WK. Biological methylation of myelin basic protein. Arch Biochem Biophys. 1997 May;29(5):743-51.
7. Senut MC, Sen A, Cingolani P, Shaik A, Land SJ, Ruden DM. Lead exposure disrupts global DNA methylation in human embryonic stem cells. Toxicol Sci. 2014 May;139(1):142-61.
8. Ross S, Poirier L. Proceedings from the symposium on methyl balance. J Nutr. August 1, 2002 vol. 132 no. 8 2329S-2332S.
9. Yagiela JA. Health hazards and nitrous oxide. Anesth Prog. 1991 Jan-Feb;38(1):1-11.
10. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11;310(22):2435-42.
11. Pu D, Shen Y, Wu J. Association between MTHFR gene polymorphisms and autism. Psychiatry Res. 2013 Oct;6(5):384-92.
12. Rajagopalan P, Jahanshad N, Stein JL, et al. Common folate gene variant and cognitive decline. JAMA Neurol. 2012 Oct 4;1(1):179-87.
13. Peerbooms OL, van Os J, Drukker M, et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder. Mol Psychiatry. 2011 Nov;25(8):1530-43.
14. AbdRaboha N, Badrb S, Alic S. MTHFR gene polymorphism and type 2 diabetes. J Diabetes Metab. Jan 2013;14(1):87–93.
15. Wang H, Hu C, Xiao SH, Wan B. Association of MTHFR gene with type 2 diabetes. Biomed Res Int. 2014;2014:725731.
16. Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP. MTHFR polymorphism and Down syndrome. PLoS One. 2014 Sep 29;9(9):e108552.
17. Victorino DB, Godoy MF, Goloni-Bertollo EM, Pavarino EC. Meta-analysis of MTHFR gene in Down syndrome. Mol Biol Rep. 2014 Aug;41(8):5491-504.
18. Wu YL, Hu CY, Lu SS, et al. MTHFR C677T polymorphism and hypertension. Gene. 2014 Dec;63(12):1503-11.
19. Xia LZ, Liu Y, Xu XZ, et al. MTHFR polymorphism and gastric cancer risk. World J Gastroenterol. 2014 Aug 28;20(32):11429-38.
20. Zhou BS, Bu GY, Li M, Chang BG, Zhou YP. MTHFR gene polymorphisms and ischemic stroke. Asian Pac J Cancer Prev. 2014 May 20;15(5):8931-40.
21. Liu R, Geng P, Ma M, et al. MTHFR C677T polymorphism and migraine risk. J Neurol Sci. 2014 Jan 15;336(1-2):68-73.
22. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and neural tube defects. Blood. 1999 May 21;84(2):151-7.
23. Linnebank M, Moskau S, Semmler A, et al. MTHFR genotypes and smoking. PLoS One. 2012;7(12):e53322.
24. Rs1801133. SNPedia, 6 Aug. 2014. Web. 16 June 2015.
25. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013 Feb;15(2):153-6.
26. Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015 Jul 7;132(1):e6-9.